Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.57 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.53 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CETP | P11597 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 3/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29245563 | 1.00 | FAAH (0.57) | FAAHASAH2SMN1; SMN2SLC6A5DEGS1 | |
| SCHEMBL10723388 | 0.91 | FAAH (0.58) | FAAHALDH1A1CNR2TRPV1CNR1 | |
| SCHEMBL5673619 | 0.82 | FAAH (0.64) | FAAHASAH2SLC6A5DEGS1ALDH1A1 | |
| SCHEMBL5673658 | 0.82 | FAAH (0.64) | FAAHASAH2SLC6A5DEGS1ALDH1A1 | |
| SCHEMBL8435127 | 0.81 | ALDH1A1 (0.54) | FAAHSMN1; SMN2ALDH1A1TP53CNR1 | |
| SCHEMBL1514267 | 0.81 | ALDH1A1 (0.54) | FAAHSMN1; SMN2ALDH1A1TP53CNR1 | |
| SCHEMBL8435136 | 0.81 | ALDH1A1 (0.54) | FAAHSMN1; SMN2ALDH1A1TP53CNR1 | |
| SCHEMBL16011202 | 0.80 | FAAH (0.60) | FAAHASAH2SMN1; SMN2SLC6A5DEGS1 | |
| SCHEMBL2058960 | 0.80 | FAAH (0.60) | FAAHASAH2SLC6A5DEGS1CETP | |
| SCHEMBL16011422 | 0.80 | FAAH (0.60) | FAAHASAH2SMN1; SMN2SLC6A5DEGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384508-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | claimed |
| US-11866723-B2 | Plant virus movement proteins and methods of using same | Molecular Transfer Inc. (US) | 2024-01-09 | — | — | US | claimed |
| EP-4175967-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2023-05-10 | — | — | EP | claimed |
| WO-2023018990-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2022006368-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2022-01-06 | — | — | WO | claimed |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2021-04-06 | — | — | US | claimed |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-12-18 | — | — | US | claimed |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2017-02-02 | — | — | US | claimed |
| EP-2912045-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2015-09-02 | — | — | EP | claimed |
| WO-2014070687-A2 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2014-05-08 | — | — | WO | claimed |
| EP-2696678-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2014-02-19 | — | — | EP | claimed |
| WO-2013158127-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2013-10-24 | — | — | WO | claimed |
| EP-2015780-B1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2012-12-12 | — | — | EP | claimed |
| WO-2012142622-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-10-18 | — | — | WO | claimed |
| US-7915230-B2 | Reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER (US) | 2009-01-22 | — | — | US | claimed |
| EP-2015780-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2009-01-21 | — | — | EP | claimed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | claimed |
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2024-07-23 | — | — | US | disclosed |
| WO-2024145435-A2 | LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS | Life Technologies Corporation (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4384508-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024031051-A1 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | Life Technologies Corporation | 2024-01-04 | — | — | US | disclosed |
| WO-2024006937-A1 | LIPID COMPOSITIONS FOR IN VIVO DELIVERY | Life Technologies Corporation (US) | 2024-01-04 | — | — | WO | disclosed |
| EP-4175967-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2023-05-10 | — | — | EP | disclosed |
| WO-2023018990-A2 | LIPIDS FOR NUCLEIC ACID DELIVERY | Life Technologies Corporation (US) | 2023-02-16 | — | — | WO | disclosed |
| US-20220002716-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation | 2022-01-06 | — | — | US | disclosed |
| WO-2022006368-A2 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | Life Technologies Corporation (US) | 2022-01-06 | — | — | WO | disclosed |
| US-20210323984-A1 | POL YCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. | 2021-10-21 | — | — | US | disclosed |
| US-11085056-B2 | Transfection complexes and methods of using the same | MOLECULAR TRANSFER, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| US-20210189433-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2021-06-24 | — | — | US | disclosed |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-10883118-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | Molecular Transfer Inc. (US) | 2021-01-05 | — | — | US | disclosed |
| US-20190352316-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2019-11-21 | — | — | US | disclosed |
| EP-2696678-B1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2019-11-20 | — | — | EP | disclosed |
| US-20190264230-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2019-08-29 | — | — | US | disclosed |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-12-18 | — | — | US | disclosed |
| US-20180340188-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | MOLECULAR TRANSFER, INC. (US) | 2018-11-29 | — | — | US | disclosed |
| US-10138497-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2018-11-27 | — | — | US | disclosed |
| US-20180237790-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | FORREST INNOVATIONS LTD. (IL) | 2018-08-23 | — | — | US | disclosed |
| EP-3334831-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | Forrest Innovations Ltd. (IL) | 2018-06-20 | — | — | EP | disclosed |
| US-20180002724-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2018-01-04 | — | — | US | disclosed |
| EP-2604255-B1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER INC (US) | 2017-10-25 | — | — | EP | disclosed |
| US-9765359-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| WO-2017025967-A1 | FORMULATIONS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS TO PLANT CELLS | FORREST INNOVATIONS LTD. (IL) | 2017-02-16 | — | — | WO | disclosed |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2017-02-02 | — | — | US | disclosed |
| US-20160130607-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer Inc. | 2016-05-12 | — | — | US | disclosed |
| US-9259475-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2016-02-16 | — | — | US | disclosed |
| US-20140213637-A1 | Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells | Molecular Transfer Inc. (US) | 2014-07-31 | — | — | US | disclosed |
| US-8759499-B2 | Lipids for transfection of Eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| EP-2696678-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2013158127-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2013-10-24 | — | — | WO | disclosed |
| EP-2604255-A1 | Novel reagents for transfection of eukaryotic cells | Molecular Transfer, Inc. (US) | 2013-06-19 | — | — | EP | disclosed |
| EP-2015780-B1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER INC (US) | 2012-12-12 | — | — | EP | disclosed |
| WO-2012142622-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-10-18 | — | — | WO | disclosed |
| US-20120052574-A1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| US-20110200624-A1 | NOVEL PEPTIDES FOR USE IN TRANSFECTION | MOLECULAR TRANSFER, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| US-7915230-B2 | Reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER, INC. (US) | 2011-03-29 | — | — | US | disclosed |
| WO-2010014915-A2 | NOVEL PEPTIDES FOR USE IN TRANSFECTION | MOLECULAR TRANSFER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | MOLECULAR TRANSFER (US) | 2009-01-22 | — | — | US | disclosed |
| EP-2015780-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | Molecular Transfer, Inc. (US) | 2009-01-21 | — | — | EP | disclosed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007130073-A2 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | MOLECULAR TRANSFER, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (20 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180340188-A1 | TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME | TIAL1, NPC1L1, LIPA | FAAH 2128/4885ASAH2 613/4885SMN1; SMN2 4171/4885 |
| US-12043639-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | FAAH 3332/4885ASAH2 1072/4885SMN1; SMN2 2031/4885 |
| US-11866723-B2 | Plant virus movement proteins and methods of using same | HDLBP, PHAX, PLTP | FAAH 3370/4885ASAH2 3573/4885SMN1; SMN2 3393/4885 |
| US-10883118-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-20140213637-A1 | Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-10968240-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | FAAH 3332/4885ASAH2 1072/4885SMN1; SMN2 2031/4885 |
| US-10138497-B2 | Agents for improved delivery of nucleic acids to eukaryotic cells | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-10155780-B2 | Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells | PHOSPHO1, MBOAT7, PLTP | FAAH 3166/4885ASAH2 811/4885SMN1; SMN2 2830/4885 |
| US-20240000966-A1 | Lipid Compositions For In Vivo Delivery | CHMP4B, LIPA, CETP | FAAH 1248/4885ASAH2 72/4885SMN1; SMN2 2806/4885 |
| US-20170029448-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | PHOSPHO1, PLTP, MBOAT7 | FAAH 3226/4885ASAH2 994/4885SMN1; SMN2 3360/4885 |
| US-20220002716-A1 | TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF | RNGTT, RNMT, CPSF7 | FAAH 4547/4885ASAH2 2798/4885SMN1; SMN2 611/4885 |
| US-20090023215-A1 | Novel reagents for transfection of eukaryotic cells | FUS, PHAX, PICALM | FAAH 3351/4885ASAH2 1978/4885SMN1; SMN2 2842/4885 |
| US-11085056-B2 | Transfection complexes and methods of using the same | TIAL1, NPC1L1, LIPA | FAAH 2128/4885ASAH2 613/4885SMN1; SMN2 4171/4885 |
| US-20210189433-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-20190352316-A1 | POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | PHOSPHO1, MBOAT7, PLTP | FAAH 3332/4885ASAH2 1072/4885SMN1; SMN2 2031/4885 |
| US-20120052574-A1 | NOVEL REAGENTS FOR TRANSFECTION OF EUKARYOTIC CELLS | FUS, PHAX, PICALM | FAAH 3351/4885ASAH2 1978/4885SMN1; SMN2 2842/4885 |
| US-20160130607-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-20210323984-A1 | POL YCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | POLRMT, PHOSPHO1, MBOAT7 | FAAH 3358/4885ASAH2 845/4885SMN1; SMN2 2318/4885 |
| US-20190264230-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
| US-20180002724-A1 | AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS | SNRPE, POLRMT, PHAX | FAAH 3537/4885ASAH2 147/4885SMN1; SMN2 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.